Nanalysis Scientific Corp.

Nanalysis Scientific Corp.

NSCIF
Nanalysis Scientific Corp.US flagOther OTC
0.09
USD
- -
- -
10.72MMarket Cap

Total Valuation

Nanalysis Scientific Corp. carries a market capitalization of 10.72M, placing it among publicly traded companies globally. Its enterprise value stands at 31.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap10.72M
Enterprise Value31.07M

Share Statistics

Nanalysis Scientific Corp. currently has 138.46M shares outstanding.

Shares Outstanding138.46M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.42, and the price-to-book ratio stands at 3.21.

PE RatioN/A
PS Ratio0.42
PB Ratio3.21
P/TBV Ratio-3.63
P/FCF Ratio7.90
P/OCF Ratio26.38

Enterprise Valuation

On an enterprise value basis, Nanalysis Scientific Corp. trades at an EV/EBITDA multiple of 214.02 and an EV/FCF ratio of 9.77.

EV / Sales0.77
EV / EBITDA214.02
EV / EBITN/A
EV / FCF9.77

Financial Position

Nanalysis Scientific Corp. maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 114.83, indicating elevated leverage, while an interest coverage ratio of -0.18 demonstrates limited ability to service its debt obligations.

Current Ratio1.02
Quick Ratio0.66
Debt / Equity114.83
Debt / EBITDA-80.37
Interest Coverage-0.18

Financial Efficiency

Return on Equity (ROE)-87.10
Return on Assets (ROA)-15.32
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover7.26

Taxes

Income Tax5,000.00
Effective Tax RateN/A

Stock Price Statistics

Nanalysis Scientific Corp.'s stock has declined approximately -52.10256% over the past 52 weeks. The 50-day moving average sits at 0.10, while the 200-day moving average is 0.12.

Beta (5Y)N/A
52-Week Price Change-52.10256%
50-Day Moving Average0.10
200-Day Moving Average0.12
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Nanalysis Scientific Corp. generated 40.20M in revenue and converted that into -5.63M in net income, yielding earnings per share of -0.05. EBITDA reached -185,000.00, while operating income came in at -3.58M.

Revenue40.20M
Gross Profit9.65M
Operating Income-3.58M
Pretax Income-5.63M
Net Income-5.63M
EBITDA-185,000.00
EBIT-3.58M
Earnings Per Share (EPS)-0.05

Balance Sheet

Nanalysis Scientific Corp. holds 731,000.00 in cash and equivalents against 14.87M in total debt, resulting in a net debt position of 12.74M. Total book value stands at 5.28M, with working capital of 250,000.00 providing operational flexibility.

Cash & Cash Equivalents731,000.00
Total Debt14.87M
Net Debt12.74M
Equity (Book Value)5.28M
Book Value Per Share0.04
Working Capital250,000.00

Cash Flow

Nanalysis Scientific Corp. produced 642,000.00 in operating cash flow over the past twelve months. After subtracting -1.50M in capital expenditures, free cash flow totaled -860,000.00 - equivalent to -0.01 per share.

Operating Cash Flow642,000.00
Capital Expenditures-1.50M
Free Cash Flow-860,000.00
FCF Per Share-0.01

Margins

Nanalysis Scientific Corp. operates with a gross margin of 23.99, reflecting its pricing power and cost economics. The operating margin of -8.89 and net profit margin of -14.01 provide insight into operational efficiency.

Gross Margin23.99
Operating Margin-8.89
Pretax Margin-14.00
Profit Margin-14.01
EBITDA Margin-0.46

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-4.51
FCF Yield12.66

Scores

Nanalysis Scientific Corp. posts an Altman Z-Score of -2.36, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-2.36